Impact of Prenatal Disorders on the Metabolic Profile of Second Trimester Amniotic Fluid: A Nuclear Magnetic Resonance Metabonomic Study
详细信息 查看全文
- 作者：Gonalo Graa ; Iola F. Duarte ; Antnio S. Barros ; Brian J. Goodfellow ; Slvia O. Diaz ; Joana Pinto ; Isabel M. Carreira ; Eullia Galhano ; Cristina Pita ; Ana M. Gil
- 刊名：Journal of Proteome Research
- 出版年：2010
- 出版时间：November 5, 2010
- 年：2010
- 卷：9
- 期：11
- 页码：6016-6024
- 全文大小：316K
- 年卷期：v.9,no.11(November 5, 2010)
- ISSN：1535-3907
文摘
This paper describes a metabonomic study of prenatal disorders using nuclear magnetic resonance (NMR) spectroscopy of amniotic fluid (AF) collected in the second trimester of pregnancy, to search for metabolite markers of fetal malformations, prediagnostic gestational diabetes (GD), preterm delivery (PTD), early rupture of membranes (PROM), and chromossomopathies. Fetal malformations were found to have the highest impact on AF metabolite composition, enabling statistical validation to be achieved by several multivariate analytical tools. Results confirmed previous indications that malformed fetuses seem to suffer altered energy metabolism and kidney underdevelopment. Newly found changes (namely in α-oxoisovalerate, ascorbate, creatinine, isoleucine, serine, threonine) suggest possible additional effects on protein and nucleotide sugar biosynthesis. Prediagnostic GD subjects showed an average increase in glucose and small decreases in several amino acids along with acetate, formate, creatinine, and glycerophosphocholine. Small metabolite changes were also observed in the AF of subjects eventually undergoing PTD and PROM, whereas no relevant changes were found for chromossomopathies (for which a low number of samples was considered). The potential value of these results for biochemical insight and prediction of prenatal disorders is discussed, as well as their limitations regarding number of samples and overlap of different disorders.